Article Versions Notes

Abdelaal G, Carter A, Cheung W, Panayiotidis M, Racey S, Tétard D, Veuger S. Novel Iron Chelator SK4 Drives Cytotoxicity through Inhibiting Mitochondrial Metabolism in Ovarian and Triple Negative Breast Cancer Cell Lines. Biomedicines. 2023; 11(7):2073. https://doi.org/10.3390/biomedicines11072073

Abdelaal, Gina, Andrew Carter, William Cheung, Mihalis Panayiotidis, Seth Racey, David Tétard, and Stephany Veuger. 2023. "Novel Iron Chelator SK4 Drives Cytotoxicity through Inhibiting Mitochondrial Metabolism in Ovarian and Triple Negative Breast Cancer Cell Lines" Biomedicines 11, no. 7: 2073. https://doi.org/10.3390/biomedicines11072073

Abdelaal, G., Carter, A., Cheung, W., Panayiotidis, M., Racey, S., Tétard, D., & Veuger, S. (2023). Novel Iron Chelator SK4 Drives Cytotoxicity through Inhibiting Mitochondrial Metabolism in Ovarian and Triple Negative Breast Cancer Cell Lines. Biomedicines, 11(7), 2073. https://doi.org/10.3390/biomedicines11072073